Skip to main content
RT @ejdein1: Draft #ACR20 Rx Recs for RA: on max tolerated MTX - add bio or tsDMARD conditional recommendation over trip

Eric Dein ejdein1

5 years 11 months ago
Draft #ACR20 Rx Recs for RA: on max tolerated MTX - add bio or tsDMARD conditional recommendation over triple therapy (MTX, HCQ, SSZ). @RheumNow. https://t.co/s6fKEW8czc
RT @ejdein1: Draft #ACR20 Rx Recs for RA: Use MTX, starting oral but remember MTX tricks to maximize success. Folic acid

Eric Dein ejdein1

5 years 11 months ago
Draft #ACR20 Rx Recs for RA: Use MTX, starting oral but remember MTX tricks to maximize success. Folic acid, split dosing, SubQ all keys per Dr. O'Dell to maximize @RheumNow. https://t.co/8K9BjotZha
Antimalarials and Retinopathy: Dr. Janet Pope

Dr. Janet Pope reviews abstract #1825 at the 2020 ACR annual meeting.

RT @RHEUMarampa: Novel predictors of early mortality in a cohort of GCA pts from Portugal:
🚩Older age at dx
🚩Tongu

sheila RHEUMarampa

5 years 11 months ago
Novel predictors of early mortality in a cohort of GCA pts from Portugal: 🚩Older age at dx 🚩Tongue claudication 🚩Prior tx w/ anticoag BP treatment at dx - predictor of early survival. @RheumNow #ACR20 abs1935 https://t.co/TGJNnZ8vTQ
RT @ejdein1: Draft #ACR20 Rx Recommendations for RA: MTX monotherapy conditionally rec over csDMARD dual or triple Rx, M

Eric Dein ejdein1

5 years 11 months ago
Draft #ACR20 Rx Recommendations for RA: MTX monotherapy conditionally rec over csDMARD dual or triple Rx, MTX+TNFi @RheumNow https://t.co/jyjRD5aadN
RT @drdavidliew: Rituximab in AAV: how to dose?

Should we be giving:
- 'haem dosing': 375mg/m2 x4 doses
- 'RA dosing':

David Liew drdavidliew

5 years 11 months ago
Rituximab in AAV: how to dose? Should we be giving: - 'haem dosing': 375mg/m2 x4 doses - 'RA dosing': 1000mg x2 doses Systematic review says: no difference Reassuring given the variation in practice in real life! #ACR20 ABST2048 @RheumNow https://t.co/Jf4Ue6HRRL
RT @DrMiniDey: Prelim. results: Immunogenicity of adjuvanted #HerpesZoster subunit #vaccine in #RheumatoidArthritis pati

Mrinalini Dey DrMiniDey

5 years 11 months ago
Prelim. results: Immunogenicity of adjuvanted #HerpesZoster subunit #vaccine in #RheumatoidArthritis patients taking #JAKinhibitors - Most RA pts on JAKi have sufficient antibody response to HZ vaccine - Acceptable safety profile Abs#1997 #ACR20 @RheumNow https://t.co/8HWAIwOATD
RT @doctorRBC: Rheumatology reimbursement by CMS:
"If all goes well, in a few months, you will see a 16% increase in rh

Robert B Chao, MD doctorRBC

5 years 11 months ago
Rheumatology reimbursement by CMS: "If all goes well, in a few months, you will see a 16% increase in rheumatology." - From ACR Advocacy Updates @RheumNow #ACR20 Abs#5M017
RT @MeralElRamahiMD: Checkout this session live now for an update on RA treatment guidelines (last updated in 2015)! #AC

Meral K. El Ramahi, MD MeralElRamahiMD

5 years 11 months ago
Checkout this session live now for an update on RA treatment guidelines (last updated in 2015)! #ACR20 @RheumNow https://t.co/Y4Ax3E4OHb
RT @MeralElRamahiMD: Poll results are in! 50% of those that responded note that they recommend breathing exercises, yoga

Meral K. El Ramahi, MD MeralElRamahiMD

5 years 11 months ago
Poll results are in! 50% of those that responded note that they recommend breathing exercises, yoga, and increase dietary intake of turmeric and ginger to their RA patients! #ACR20 @RheumNow https://t.co/04vOUOzRtj
RT @RichardPAConway: Dr Benard reports an SLR and meta-analysis of 27 studies comparing 2 rituximab regimes in AAV. 375m

Richard Conway RichardPAConway

5 years 11 months ago
Dr Benard reports an SLR and meta-analysis of 27 studies comparing 2 rituximab regimes in AAV. 375mg x4 and 1000mg x2 equivalent. Remission in 91% vs 85%. Similar adverse event rates @rheumnow #ACR20 Abstr#2048 https://t.co/I0feVuZ8iy
RT @bella_mehta: Anakinra in #Stills disease - Double blind, placebo controlled RCT in Stills disease total 12pts, 6 pla

Bella Mehta bella_mehta

5 years 11 months ago
Anakinra in #Stills disease - Double blind, placebo controlled RCT in Stills disease total 12pts, 6 placebo, 6 Rx grp. All pts reached ACR70 at week 2 without fever and sustained it at 12 weeks. 5/6 reached ACR90 @RheumNow #ACR20 ABS#1633 #ACRbest https://t.co/9E4vm7WzhP
RT @MeralElRamahiMD: Poll results are in! 48% of those that responded are not yet convinced of the benefits of omega-3 f

Meral K. El Ramahi, MD MeralElRamahiMD

5 years 11 months ago
Poll results are in! 48% of those that responded are not yet convinced of the benefits of omega-3 fish oil supplements in pts w/ RA! #ACR20 @RheumNow https://t.co/B6f8ecWj07
×